BG61678B1 - Антиисхемично лекарствено средство - Google Patents
Антиисхемично лекарствено средство Download PDFInfo
- Publication number
- BG61678B1 BG61678B1 BG99164A BG9916494A BG61678B1 BG 61678 B1 BG61678 B1 BG 61678B1 BG 99164 A BG99164 A BG 99164A BG 9916494 A BG9916494 A BG 9916494A BG 61678 B1 BG61678 B1 BG 61678B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- tetrahydro
- phenyl
- methyl
- oxo
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9209769A GB2266841A (en) | 1992-05-06 | 1992-05-06 | Compounds for use as anti-ischemic medicaments |
PCT/FI1993/000191 WO1993021921A1 (en) | 1992-05-06 | 1993-05-05 | Anti-ischemic medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
BG99164A BG99164A (bg) | 1995-08-28 |
BG61678B1 true BG61678B1 (bg) | 1998-03-31 |
Family
ID=10715082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG99164A BG61678B1 (bg) | 1992-05-06 | 1994-11-04 | Антиисхемично лекарствено средство |
Country Status (25)
Country | Link |
---|---|
US (1) | US5512572A (ko) |
EP (1) | EP0639074B1 (ko) |
JP (2) | JP3313714B2 (ko) |
KR (1) | KR100275823B1 (ko) |
AT (1) | ATE196086T1 (ko) |
AU (1) | AU665840B2 (ko) |
BG (1) | BG61678B1 (ko) |
BR (1) | BR9306314A (ko) |
CA (1) | CA2134972C (ko) |
CZ (1) | CZ283259B6 (ko) |
DE (1) | DE69329381T2 (ko) |
DK (1) | DK0639074T3 (ko) |
ES (1) | ES2150445T3 (ko) |
FI (1) | FI945052A0 (ko) |
GB (1) | GB2266841A (ko) |
GR (1) | GR3034896T3 (ko) |
HU (1) | HU222349B1 (ko) |
NO (1) | NO306236B1 (ko) |
NZ (1) | NZ252693A (ko) |
PT (1) | PT639074E (ko) |
RO (1) | RO115781B1 (ko) |
RU (1) | RU2146142C1 (ko) |
SK (1) | SK279580B6 (ko) |
UA (1) | UA35584C2 (ko) |
WO (1) | WO1993021921A1 (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9614098D0 (en) | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
FI973804A (fi) | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
FI974578A (fi) * | 1997-12-19 | 1999-06-20 | Orion Yhtymae Oyj | Menetelmä levosimendaanin antamiseksi |
FI980901A (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
FI980902A (fi) | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaanin stabiileja koostumuksia |
FI104718B (fi) * | 1998-06-18 | 2000-03-31 | Orion Yhtymae Oyj | [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä |
FI981473A (fi) | 1998-06-25 | 1999-12-26 | Orion Yhtymae Oyj | Menetelmä pulmonaalihypertension hoitamiseksi |
GB9915179D0 (en) | 1999-06-29 | 1999-09-01 | Orion Corp | A method for the treatment or prevention of coronary graft vasospasm |
FI109659B (fi) * | 1999-09-10 | 2002-09-30 | Orion Yhtymae Oyj | Levosimendaanin farmaseuttisia liuoksia |
DE60016038T2 (de) | 1999-10-22 | 2005-12-22 | Orion Corp. | Neue verwendung von levosimendan |
FI20001542A (fi) * | 2000-06-29 | 2001-12-30 | Orion Yhtymae Oyj | Menetelmä septisen sokin hoitamiseksi |
FI20002526A (fi) * | 2000-11-17 | 2002-05-18 | Orion Yhtymae Oyj | Pyridatsinonijohdannaisten uusi käyttö |
FI20002755A0 (fi) | 2000-12-15 | 2000-12-15 | Orion Yhtymae Oyj | Menetelmä erektiilin dysfunktion hoitamiseen |
JP2002211346A (ja) * | 2001-01-15 | 2002-07-31 | Takata Corp | インフレータ |
FI20010233A0 (fi) | 2001-02-08 | 2001-02-08 | Orion Corp | Menetelmä sydämen vajaatoiminnan hoitoon |
FI20020197A0 (fi) * | 2002-02-01 | 2002-02-01 | Orion Corp | Yhdistelmä akuutin myokardiilisen infarktin hoitoon |
US8618316B1 (en) | 2004-03-05 | 2013-12-31 | Stepan Company | Low temperature ramp rate ester quat formation process |
FI20040675A0 (fi) * | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä sydämen hypertrofian hoitoon ja estoon |
FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
CA2568393A1 (en) * | 2004-05-28 | 2005-12-15 | Abbott Laboratories | Methods for treating a mammal before, during and after cardiac arrest |
WO2012093404A2 (en) | 2011-01-03 | 2012-07-12 | Gufic Biosciences Limited | Parenteral formulations of levosimendan |
CN105784895B (zh) * | 2015-10-30 | 2018-05-22 | 成都欣捷高新技术开发有限公司 | 一种用高效液相色谱仪检测左西孟旦中杂质的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4962110A (en) * | 1985-03-12 | 1990-10-09 | Smith Kline & French Laboratories Limited | Pyridazinone derivatives |
GB8603780D0 (en) * | 1986-02-15 | 1986-03-19 | Smith Kline French Lab | Chemical compounds |
GB8722776D0 (en) * | 1987-09-28 | 1987-11-04 | Smith Kline French Lab | Chemical compounds |
FI884418A (fi) * | 1987-10-05 | 1989-04-06 | Fujisawa Pharmaceutical Co | Hjaertskyddande aemne och ett terapeutiskt aemne foer ischemiska sjukdomar omfattande n-innehaollande heterocykliska foereningar, och ett foerfarande foer framstaellning av dessa foereningar. |
GB8903130D0 (en) * | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
US5109575A (en) * | 1991-06-10 | 1992-05-05 | Signode Corporation | Toothed seal for hard thermoplastic strap |
-
1992
- 1992-05-06 GB GB9209769A patent/GB2266841A/en not_active Withdrawn
-
1993
- 1993-05-05 EP EP93911803A patent/EP0639074B1/en not_active Expired - Lifetime
- 1993-05-05 AU AU42627/93A patent/AU665840B2/en not_active Ceased
- 1993-05-05 US US08/331,607 patent/US5512572A/en not_active Expired - Lifetime
- 1993-05-05 UA UA94095878A patent/UA35584C2/uk unknown
- 1993-05-05 CA CA002134972A patent/CA2134972C/en not_active Expired - Fee Related
- 1993-05-05 RU RU94046070A patent/RU2146142C1/ru not_active IP Right Cessation
- 1993-05-05 CZ CZ942720A patent/CZ283259B6/cs not_active IP Right Cessation
- 1993-05-05 KR KR1019940703883A patent/KR100275823B1/ko not_active IP Right Cessation
- 1993-05-05 AT AT93911803T patent/ATE196086T1/de not_active IP Right Cessation
- 1993-05-05 JP JP51897393A patent/JP3313714B2/ja not_active Expired - Fee Related
- 1993-05-05 NZ NZ252693A patent/NZ252693A/en not_active IP Right Cessation
- 1993-05-05 DE DE69329381T patent/DE69329381T2/de not_active Expired - Fee Related
- 1993-05-05 SK SK1324-94A patent/SK279580B6/sk unknown
- 1993-05-05 DK DK93911803T patent/DK0639074T3/da active
- 1993-05-05 ES ES93911803T patent/ES2150445T3/es not_active Expired - Lifetime
- 1993-05-05 PT PT93911803T patent/PT639074E/pt unknown
- 1993-05-05 HU HU9403191A patent/HU222349B1/hu not_active IP Right Cessation
- 1993-05-05 RO RO94-01785A patent/RO115781B1/ro unknown
- 1993-05-05 WO PCT/FI1993/000191 patent/WO1993021921A1/en active IP Right Grant
- 1993-05-05 BR BR9306314A patent/BR9306314A/pt not_active Application Discontinuation
-
1994
- 1994-10-27 FI FI945052A patent/FI945052A0/fi unknown
- 1994-10-31 NO NO944145A patent/NO306236B1/no unknown
- 1994-11-04 BG BG99164A patent/BG61678B1/bg unknown
-
2000
- 2000-11-22 GR GR20000402585T patent/GR3034896T3/el not_active IP Right Cessation
-
2002
- 2002-02-08 JP JP2002033088A patent/JP2002275067A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG61678B1 (bg) | Антиисхемично лекарствено средство | |
Muller et al. | Nifedipine therapy for Prinzmetal's angina. | |
Reimer et al. | Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs. | |
JPH0649651B2 (ja) | 心筋虚血治療用医薬組成物 | |
KR20160108611A (ko) | 심방세동의 치료 방법 | |
CN1043509C (zh) | 抗氧剂羟基咔唑化合物的制药用途 | |
JP2009500365A (ja) | 再灌流障害を処置するための可溶性グアニル酸シクラーゼ活性化剤の使用 | |
CZ298745B6 (cs) | Farmaceutická kombinace, farmaceutický přípravek, způsob jeho výroby a použití kombinace | |
Stone et al. | Nifedipine therapy for recurrent ischemic pain following myocardial infarction | |
EP0412901A2 (fr) | Utilisation de trifluorométhyl-phényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles de la motricité intestinale | |
CN1042795C (zh) | 抗氧剂羟基咔唑化合物保护神经的用途及用其治疗的方法 | |
KR930001105B1 (ko) | 심부정맥 예방 또는 치료용약제 | |
HU212941B (en) | Process for producing synergetic, antihypertensive pharmaceutical compositions containing verapamil and trandolapril | |
WO2000025773A1 (en) | Pharmaceutical combination of mildronate and enalapril | |
EA004142B1 (ru) | Способ лечения или профилактики вазоспазма коронарного трансплантата | |
JP6336484B2 (ja) | 遅延ナトリウム電流遮断薬および洞房結節if電流阻害薬の組合せ、ならびに該組合せを含む医薬組成物 | |
JPH01283224A (ja) | 抗高血圧の組み合わせ調合物 | |
HU212502B (en) | Process for producing pharmaceutical preparative containing n-methyl-2-(3-pyridyl)-tetrahydrothiopyrane-2-carbothioamide-1-oxide applicable for treating insufficiency of coronary arteries | |
REIMER et al. | Effect of the Calcium Antagonist Verapamil on Necrosis following Temporary Coronary Artery | |
HUT52384A (en) | Process for producing pharmaceutical compositions comprising dianhydrohexitol acyl derivatives |